1. Desialylation of Atg5 by sialidase (Neu2) enhances autophagosome formation to induce anchorage-dependent cell death in ovarian cancer cells
   Eswara Murali Satyavarapu et al, 2021, Cell Death Discovery CrossRef
2. Targeting XIAP and PPARγ in Granulosa Cell Tumors Alters Metabolic Signaling
   Dilys T. H. Leung et al, 2019, Journal of Proteome Research CrossRef
3. Knockdown of miR-27a sensitizes colorectal cancer stem cells to TRAIL by promoting the formation of Apaf-1-caspase-9 complex
   Rui Zhang et al, 2017, Oncotarget CrossRef
4. Multifaceted Evaluation of Inhibitors of Anti-Apoptotic Proteins in Head and Neck Cancer: Insights from In Vitro, In Vivo, and Clinical Studies (Review)
   Kamil Krzykawski et al, 2024, Pharmaceuticals CrossRef
5. Tetralogy of Fallot: variants of MYH6 gene promoter and cellular functional analyses
   Ji-Yang Zuo et al, 2024, Pediatric Research CrossRef
6. Targeting of X-linked inhibitor of apoptosis protein and PI3-kinase/AKT signaling by embelin suppresses growth of leukemic cells
   Kirti S. Prabhu et al, 2017, PLOS ONE CrossRef
7. Embelin: A novel XIAP inhibitor for the prevention and treatment of chronic diseases
   Uzini Devi Daimary et al, 2022, Journal of Biochemical and Molecular Toxicology CrossRef
8. X-linked inhibitor of apoptosis protein (XIAP) inhibition in systemic sclerosis (SSc)
   Christina Bergmann et al, 2021, Annals of the Rheumatic Diseases CrossRef
9. Potential biological process of X‑linked inhibitor of apoptosis protein in renal cell carcinoma based upon differential protein expression analysis
   Chao Chen et al, 2017, Oncology Letters CrossRef
10. The XIAP inhibitor embelin sensitises malignant rhabdoid tumour cells to TRAIL treatment via enhanced activation of the extrinsic apoptotic pathway
    Rachel Coyle et al, 2019, International Journal of Oncology CrossRef
11. Embelin: A Benzoquinone Possesses Therapeutic Potential for the Treatment of Human Cancer
    Kirti S Prabhu et al, 2018, Future Medicinal Chemistry CrossRef